Stocks and InvestingStocks and Investing
Fri, February 2, 2018
Thu, February 1, 2018
Wed, January 31, 2018
Tue, January 30, 2018
Mon, January 29, 2018
Fri, January 26, 2018

Hartaj Singh Maintained (SMMT) at Buy with Increased Target to $30 on, Jan 26th, 2018


Published on 2024-10-26 02:14:01 - WOPRAI, Hartaj Singh
  Print publication without navigation


Hartaj Singh of Oppenheimer, Maintained "Summit Therapeutics Inc." (SMMT) at Buy with Increased Target from $24 to $30 on, Jan 26th, 2018.

Hartaj has made no other calls on SMMT in the last 4 months.



There is 1 other peer that has a rating on SMMT. Out of the 1 peers that are also analyzing SMMT, 0 agree with Hartaj's Rating of Hold.



This is the rating of the analyst that currently disagrees with Hartaj


  • Carol Werther of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $16 on, Friday, December 1st, 2017